Table 1.
Indices of adiposity and metabolic markers at baseline survey and at follow-up 5 years later.
| Baseline | Follow - up | |
|---|---|---|
| N | 73 | 73 |
| Age (y) | 40.8 ± 10.8 | |
| Body weight (kg) | 60.0 ± 13.9 | 63.1 ± 15.0*** |
| Waist (cm) | 84.1 ± 12.5 | 91.3*** |
| BMI (kg/m2) | 25.9 ± 5.5 | 27.2*** |
| Percentage fat mass (%) | 35.2 ± 5.4 | 36.7 ± 5.1** |
| Fat mass kg | 23.1 ± 8.1 | 23.7 ± 8.0** |
| P-glucose (mmol/L) | 4.12 ± 0.45 | 5.01 ± 1.25*** |
| Insulin (pmol/L) | 80.9 ± 42.6 | 83.4 ± 62.9 |
| HOMA -IR | 15.2 ± 9.1 | 19.0 ± 15.5** |
| Interleukin-6 (pg/mL) | 2.03 ± 2.49 | 1.89 ± 1.50 |
| TNF-α(pg/mL) | 4.43 ± 5.98 | 3.35 ± 3.85** |
All values are means ± SD. HOMA-IR = homeostasis model of assessment ratio. TNF-α = tumor necrosis factor alpha. Significant differences during the follow-up period are represented by < 0.05*, < 0.01** and < 0.001*** (Wilcoxon signed rank test).